Read More: Novo’s $1,000 Diabetes Drug Can Be Made for Under $5 a Month Sanders’ inquiry came after a study published in JAMA ...
Megan Tjelle lost 55 pounds through walking and eating in a calorie deficit. She then went on weight loss drug Wegovy to lose ...
Sen. Bernie Sanders, chair of the Senate Health, Education, Labor and Pensions Committee, has demanded to know why Americans ...
A little over a year ago, the 58-year-old man went on a new weight loss drug called Wegovy. He's lost 30 pounds, and has ...
Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
Lilly’s newest obesity and diabetes medicines, widely known as GLP-1 drugs, are drawing rave reviews from doctors, researchers and patients for their ability to safely and effectively control blood ...
Eli Lilly and Novo are leading now, but there are multiple drug candidates waiting in the wings that could disrupt that duopoly in the future.
An antiques shop owner in Maine was hired by a friend to value the collection of the artist Robert Indiana. His verdict was ...
Building on the continued momentum behind its GLP-1 drugs, the pharma company’s parent company, Novo Holdings, announced a ...
The company, which also makes Ozempic for type 2 diabetes, has been limiting how much of the lowest doses of Wegovy it has ...
Shares of DoorDash were down 14% after it reported a first-quarter loss that was wider than analysts' estimates. DoorDash said it expects gross order value of $19 billion to $19.4 billion in the ...